The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising ...

Biochemist Svetlana Mojsov, honored for GLP-1 research that has transformed metabolic disease care, says she’s grateful to ...

Discover why Takeda Pharmaceutical Company Limited remains a solid Buy. Click to explore TAK and its drug pipeline, growth ...

Trump floated proposed tariffs potentially as high as 200 per cent. But he also said these would not be imposed for “ about a ...

Analysts are calling for 25% top-line growth from Intuitive Surgical this year, to be followed by 15% and 17% revenue growth ...

Would you get a one-time genetic modification such that you'd never have to take a GLP-1 drug for weight loss ever again?

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

83% of pharmaceutical companies—including many contract development and manufacturing organizations (CDMOs)—operate without basic technical safeguards.

The White House’s latest travel ban imposes restrictions on citizens from nineteen countries, many of which are contending with crises at home. Another thirty-six could be next.